Dr Kati Matthiesson

Dr Kati Matthiesson graduated from the University of Melbourne in 1990 and undertook her basic training at St Vincent's Hospital in Melbourne and St Vincent's Medial Centre in Bridgeport, Connecticut, USA.

On her return to Australia in 1998, she completed her training in Endocrinology at Monash Medical Centre including a PhD at Monash University and the University of Washington, Seattle in 2006. Her research focused on the hormonal regulation of spermatogenesis and the implications for male fertility.
She is a Senior Consultant at Monash Health and an Adjunct Senior Clinical Lecturer at Monash University. 

Outside of work, Dr Matthiesson likes to spend time with family and friends. She is a keen horse-riding enthusiast and has competed in amateur riding competitions around Australia.

Her current clinical interests include general endocrinology and diabetes and in particular pituitary disease, polycystic ovarian syndrome and obesity management.

Selected publications

McCabe MJ, Tarulli GA, Laven-Law G, Matthiesson KL, Meachem SJ, McLachlan RI, Dinger ME and Stanton PG. Gonadotropin suppression in men leads to a reduction in claudin-11 at the Sertoli cell tight junction. 2016 Hum Reprod. Feb : 31(4):875-886.

Allan CA, Collins VR, Frydenberg M, McLachlan RI, Matthiesson KL. Androgen Deprivation Therapy Complications. 2013 Endocrine Related Cancer Aug: 21(4):T119-29

Allan CA, Collins VR, Frydenberg M, McLachlan RI, Matthiesson KL. Monitoring cardiovascular health in men with prostate cancer treated with Androgen Deprivation Therapy. International Journal of Urological Nursing 2012 Mar: 6(1):35-41

Ruwanpura SM, McLachlan RI, Matthiesson KL, Meachem SJ. Gonadotrophins regulate germ cell survival, not proliferation, in normal adult men. Hum Reprod. 2008 Feb;23(2):403-11.

Matthiesson KL, McLachlan RI, O'Donnell L, Frydenberg M, Robertson DM, Stanton PG, Meachem SJ. The relative roles of FSH and LH in maintaining spermatogonial maturation and spermiation in normal men. J Clin Endocrinol Metab. 2006 Oct;91(10):3962-9. Epub 2006 Aug 8.

Matthiesson KL, McLachlan RI. Male hormonal contraception: concept proven, product in sight? Hum Reprod Update. Hum Reprod Update. 2006 Jul-Aug;12(4):463-82. Epub 2006 Apr 5. (Translated into Japanese with Figure used as Front Cover Art)

Bay K, Matthiesson KL, McLachlan RI, Andersson AM. The effects of gonadotropin suppression and selective replacement on insulin-like factor 3 secretion in normal adult men. J Clin Endocrinol Metab. 2006 Mar;91(3):1108-11. Epub 2006 Jan 4.

Matthiesson KL, Stanton PG, O'Donnell L, Meachem SJ, Amory JK, Berger R, Bremner WJ, McLachlan RI. Effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist on spermatogenesis and intratesticular steroid levels in normal men. J Clin Endocrinol Metab. 2005 Oct;90(10):5647-55. Epub 2005 Jul 19.

Matthiesson KL, Amory JK, Berger R, Ugoni A, McLachlan RI, Bremner WJ. Novel male hormonal contraceptive combinations: the hormonal and spermatogenic effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist. J Clin Endocrinol Metab. 2005 Jan;90(1):91-7. Epub 2004 Oct 27.

Matthiesson KL, Robertson DM, Burger HG, McLachlan RI. Response of serum inhibin B and pro-alphaC levels to gonadotrophic stimulation in normal men before and after steroidal contraceptive treatment. Hum Reprod. 2003 Apr;18(4):734-43.

Holley JL, Bia MJ, Matthiesson K, Culleton BF, Harnett JD, Bennett WM. What is the best approach to asymptomatic coronary artery disease in dialysis patients seeking transplantation? Sem Dial. 1995;8:204-211.

Professional Memberships

• Royal Australasian College of Physicians
• Endocrine Society of Australia
• Fertility Society of Australia
• Endocrine Society (US)